WEHI 164 subclone 13 assay for TNF: sensitivity, specificity, and reliability

Area of Science:

• Immunology
• Biochemistry
• Assay Development

Background:

• Tumor necrosis factor alpha (TNF) is a key peptide monokine in immune responses.
• Understanding TNF's role in disease requires sensitive and specific detection assays.
• Limited data exists on how common drugs affect TNF in biological samples.

Purpose of the Study:

• To assess the sensitivity and specificity of a WEHI cell line for TNF detection.
• To investigate the stability of TNF in biological fluids under various conditions.
• To evaluate the impact of specific compounds on TNF detection using the WEHI assay.

Main Methods:

• Utilized a WEHI cell line assay to measure TNF cytolytic activity.
• Tested the effect of prostaglandin E2 (PGE2), dexamethasone (dex), and cyclosporine A (CsA) on the assay.
• Assessed TNF stability in samples with fetal calf serum and tissue culture media through freeze-thaw cycles.

Main Results:

• The WEHI assay demonstrated high sensitivity and specificity for TNF detection.
• PGE2, dexamethasone, and cyclosporine A did not interfere with the WEHI assay's performance.
• TNF samples with fetal calf serum were stable through multiple freeze-thaw cycles, unlike those in tissue culture media.

Conclusions:

• The WEHI assay is a sensitive, specific, and reproducible method for detecting TNF activity.
• The assay is robust and unaffected by common immunosuppressive and anti-inflammatory agents.
• This assay is suitable for studying TNF in various biological fluids and disease states.